Type 2 Diabetes Patients Weary Of Byetta

September 29, 2008 · Filed Under Disease · Comment 

Byetta (exenatide) is a type 2 diabetes treatment that controls glucose, or blood sugar, levels in individuals who are non-insulin dependent. The injectable drug, manufactured by Amylin Pharmaceuticals and Eli Lilly, was approved for market use in 2005. Read more